Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Allogene Therapeutics to Report Second Quarter 2022 Financial Results on August 9, 2022
      Biotech

      Allogene Therapeutics to Report Second Quarter 2022 Financial Results on August 9, 2022

      August 1, 2022
      European Medicines Agency’s Emergency Task Force Has Initiated the Review of Veru’s Sabizabulin Treatment for Hospitalized COVID-19 Patients for Emergency Use in European Union Countries
      Biotech

      European Medicines Agency’s Emergency Task Force Has Initiated the Review of Veru’s Sabizabulin Treatment for Hospitalized COVID-19 Patients for Emergency Use in European Union Countries

      August 1, 2022
      Histogen to Report Second Quarter 2022 Financial Results and Provide Business Update
      Biotech

      Histogen to Report Second Quarter 2022 Financial Results and Provide Business Update

      August 1, 2022
      Myovant Sciences Announces Corporate Updates and Financial Results for First Fiscal Quarter 2022
      Biotech

      Myovant Sciences Announces Corporate Updates and Financial Results for First Fiscal Quarter 2022

      August 1, 2022
      Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Monitoring Minimal Residual Disease in Diffuse Large B-Cell Lymphoma
      Biotech

      Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Monitoring Minimal Residual Disease in Diffuse Large B-Cell Lymphoma

      August 1, 2022
      Arcadia Biosciences (RKDA) Announces Date of Second Quarter 2022 Financial Results and Business Highlights Conference Call
      Biotech

      Arcadia Biosciences (RKDA) Announces Date of Second Quarter 2022 Financial Results and Business Highlights Conference Call

      August 1, 2022
      Veru to Report Fiscal 2022 Third Quarter Financial Results, Host Conference Call on August 11th
      Biotech

      Veru to Report Fiscal 2022 Third Quarter Financial Results, Host Conference Call on August 11th

      August 1, 2022
      Bionano Genomics to Report Second Quarter 2022 Financial Results and Host a Conference Call and Webcast on August 4, 2022
      Biotech

      Bionano Genomics to Report Second Quarter 2022 Financial Results and Host a Conference Call and Webcast on August 4, 2022

      August 1, 2022
      Relay Therapeutics to Announce Second Quarter 2022 Financial Results and Corporate Highlights
      Biotech

      Relay Therapeutics to Announce Second Quarter 2022 Financial Results and Corporate Highlights

      August 1, 2022
      Travere Therapeutics to Report Second Quarter 2022 Financial Results
      Biotech

      Travere Therapeutics to Report Second Quarter 2022 Financial Results

      August 1, 2022
      « 1 … 123 124 125 126 127 … 134 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026